» Articles » PMID: 23504409

The Role of Myeloperoxidase and Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCAs) in the Pathogenesis of Human MPO-ANCA-associated Glomerulonephritis

Overview
Publisher Springer
Specialty Nephrology
Date 2013 Mar 19
PMID 23504409
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

It is well known that antineutrophil cytoplasmic antibodies (ANCAs) are pathogenic and have a diagnostic value for ANCA-associated vasculitis. We demonstrated that a rise in myeloperoxidase (MPO)-ANCA titers during remission is often predictive of a future relapse in MPO-ANCA-associated vasculitis. Pathological examination of renal biopsies indicated that not only MPO-ANCAs, but also extracellular MPO, an in situ immune complex composed of MPO and MPO antibodies, may play important roles in the pathogenesis of glomerular capillary injury in MPO-ANCA-associated vasculitis.

Citing Articles

Acute interstitial nephritis caused by ANCA-associated vasculitis: a case based review.

Muhammad A, Xiao Z, Lin W, Zhang Y, Meng T, Ning J Clin Rheumatol. 2023; 43(3):1227-1244.

PMID: 37932622 DOI: 10.1007/s10067-023-06798-z.


Interstitial nephritis without glomerulonephritis in ANCA-associated vasculitis: a case series and literature review.

He X, Wen Y, Hu R, Wu H, Ye W, Yue C Clin Rheumatol. 2022; 41(11):3551-3563.

PMID: 35759125 PMC: 9568481. DOI: 10.1007/s10067-022-06264-2.


Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome.

Yu C, Zhan X, Liang T, Chen L, Zhang Z, Jiang J Front Immunol. 2021; 12:572592.

PMID: 34880852 PMC: 8647161. DOI: 10.3389/fimmu.2021.572592.


Targeting neutrophil extracellular traps in severe acute pancreatitis treatment.

Hu J, Kang H, Chen H, Yao J, Yi X, Tang W Therap Adv Gastroenterol. 2020; 13:1756284820974913.

PMID: 33281940 PMC: 7692350. DOI: 10.1177/1756284820974913.


Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.

Antonelou M, Michaelsson E, Evans R, Wang C, Henderson S, Walker L J Am Soc Nephrol. 2019; 31(2):350-364.

PMID: 31879336 PMC: 7003306. DOI: 10.1681/ASN.2019060618.


References
1.
Charles L, Caldas M, Falk R, Terrell R, Jennette J . Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol. 1991; 50(6):539-46. DOI: 10.1002/jlb.50.6.539. View

2.
Kawashima S, Arimura Y, Sano K, Kudo A, Komagata Y, Kaname S . Immunopathologic co-localization of MPO, IgG, and C3 in glomeruli in human MPO-ANCA-associated glomerulonephritis. Clin Nephrol. 2013; 79(4):292-301. DOI: 10.5414/cn107675. View

3.
Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Nakabayashi K, Kitamoto K . Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol. 1993; 40(5):256-64. View

4.
Xing G, Chen M, Liu G, Heeringa P, Zhang J, Zheng X . Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol. 2008; 29(3):282-91. DOI: 10.1007/s10875-008-9268-2. View

5.
Brouwer E, Huitema M, Klok P, de Weerd H, Tervaert J, Weening J . Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med. 1993; 177(4):905-14. PMC: 2190976. DOI: 10.1084/jem.177.4.905. View